Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 10, 2007
Diabetes Care 30:1539-1543, 2007
DOI: 10.2337/dc06-2397
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2397v1
30/6/1539    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAuley, P. A.
Right arrow Articles by Froelicher, V. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAuley, P. A.
Right arrow Articles by Froelicher, V. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Exercise Capacity and Body Mass as Predictors of Mortality Among Male Veterans With Type 2 Diabetes

Paul A. McAuley, PHD, Jonathan N. Myers, PHD, Joshua P. Abella, MD, Swee Y. Tan, MD and Victor F. Froelicher, MD

From the Cardiology Division, VA Palo Alto Health Care System/Stanford University, Palo Alto, California

Address correspondence and reprint requests to Paul McAuley, PHD, VA Palo Alto Health Care System, Cardiology 111C, 3801 Miranda Ave., Palo Alto, CA 94304. E-mail: pamcauley{at}verizon.net

OBJECTIVE—To demonstrate the relation of exercise capacity and BMI to mortality in a population of male veterans with type 2 diabetes.

RESEARCH DESIGN AND METHODS—After excluding two underweight patients (BMI <18.5 kg/m2), the study population comprised 831 consecutive patients with type 2 diabetes (mean age 61 ± 9 years) referred for exercise testing for clinical reasons between 1995 and 2006. Exercise capacity was determined from a maximal exercise test and measured in metabolic equivalents (METs). Patients were classified both according to BMI category (18.5–24.9, 25.0–29.9, and ≥30 kg/m2) and by exercise capacity (<5.0 or ≥5.0 maximal METs). The association among exercise capacity, BMI, other clinical variables, and all-cause mortality was assessed by Cox proportional hazards. Study participants were followed for mortality up to 30 June 2006.

RESULTS—During a mean follow-up of 4.8 ± 3.0 years, 112 patients died, for an average annual mortality rate of 2.2%. Each 1-MET increase in exercise capacity conferred a 10% survival benefit (hazard ratio 0.90 [95% CI 0.82–0.98]; P = 0.01), but BMI was not significantly associated with mortality. After adjustment for age, ethnicity, examination year, BMI, presence of cardiovascular disease (CVD), and CVD risk factors, diabetic patients achieving <5 maximal METs were 70% more likely to die (1.70 [1.13–2.54]) than those achieving ≥5 maximal METs.

CONCLUSIONS—There was a strong inverse association between exercise capacity and mortality in this cohort of men with documented diabetes, and this relationship was independent of BMI.

Abbreviations: ACLS, Aerobics Center Longitudinal Study • CVD, cardiovascular disease • MET, metabolic equivalent • VETS, Veterans Exercise Testing Study


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Pagel-Langenickel, D. R. Schwartz, R. A. Arena, D. C. Minerbi, D. Thor. Johnson, M. A. Waclawiw, R. O. Cannon III, R. S. Balaban, D. J. Tripodi, and M. N. Sack
A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2659 - H2666.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. F. E. Praet and L. J. C. van Loon
Optimizing the therapeutic benefits of exercise in Type 2 diabetes
J Appl Physiol, October 1, 2007; 103(4): 1113 - 1120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.